Concepedia

Iwao Ohizumi

IO

19

Publications

915

Citations

14

H-Index

1997

Active since

Affiliations

Chugai Pharma (United States)(Current)

The University of Osaka

Showa Pharmaceutical University

The University of Tokyo

Osaka University of Pharmaceutical Sciences

Iwao Ohizumi is an author at Chugai Pharma (United States) specializing in medicine, immunology, and tumor microenvironment.

Top concepts

Publications per year

1997–2011

19

Publications

19

Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma

Yoshitaka Hippo, Kiyotaka Watanabe, Akira Watanabe et al. · Cancer Research · 2004 · 294 citations · Full text

Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer

Takahiro Ishiguro, Masamichi Sugimoto, Yasuko Kinoshita et al. · Cancer Research · 2008 · 176 citations

Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells

Kiyotaka Nakano, Tetsuro Orita, Jun‐ichi Nezu et al. · Biochemical and Biophysical Research Communications · 2008 · 109 citations

, , +7

Viral envelope protein gp64 transgenic mouse facilitates the generation of monoclonal antibodies against exogenous membrane proteins displayed on baculovirus

Ryoichi Saitoh, Toshihiko Ohtomo, Yoshiki Yamada et al. · Journal of Immunological Methods · 2007 · 43 citations

, , +8

Association of CD44 with OTS-8 in tumor vascular endothelial cells

Iwao Ohizumi, Naoki Harada, Kenji Taniguchi et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2000 · 40 citations

, , +7

Rows per page

1–5 of 19